BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34615391)

  • 1. Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.
    Li L; Xing S; Wu M; Ao Y; Zheng X; Cai R; Han R; Li J; Li X; Zeng Q
    Cancer Control; 2021; 28():10732748211048292. PubMed ID: 34615391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of fecal carcinoembryonic antigen as diagnosis marker for adenomatous polyposis coli and asymptomatic colorectal cancer.
    Li L; Gu W; Wu X; Ao Y; Song Y; Li X; Zeng Q
    Therap Adv Gastroenterol; 2021; 14():17562848211062792. PubMed ID: 34987605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of Fecal Carcinoembryonic Antigen for Noninvasive Detection of Colorectal Cancer: A Systematic Review.
    Li X; Stassen L; Schrotz-King P; Zhao Z; Cardoso R; Raut JR; Bhardwaj M; Brenner H
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating CEA-IgM complexes in early stage colorectal cancer.
    Castaldi F; Marino M; Beneduce L; Belluco C; De Marchi F; Mammano E; Nitti D; Lise M; Fassina G
    Int J Biol Markers; 2005; 20(4):204-8. PubMed ID: 16398401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
    Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
    Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer.
    Pellegrini P; Contasta I; Berghella AM; Gargano E; Mammarella C; Adorno D
    Cancer Immunol Immunother; 2000 Sep; 49(7):388-94. PubMed ID: 10999465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
    Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
    Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].
    Li R; Gao Z; Dong K; Wang H; Zhang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):175-180. PubMed ID: 30890505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.
    Liang Y; Tang W; Huang T; Gao Y; Tan A; Yang X; Zhang H; Hu Y; Qin X; Li S; Zhang S; Mo L; Liang Z; Shi D; Huang Z; Guan Y; Zhou J; Winkler C; O'Brien SJ; Xu J; Mo Z; Peng T
    PLoS One; 2014; 9(6):e97923. PubMed ID: 24941225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma heat shock protein 90-alpha have an advantage in diagnosis of colorectal cancer at early stage.
    Kasanga M; Liu L; Xue L; Song X
    Biomark Med; 2018 Aug; 12(8):881-890. PubMed ID: 29939072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Expression of
    Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
    Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.
    Kim Y; Lee S; Park S; Jeon H; Lee W; Kim JK; Cho M; Kim M; Lim J; Kang CS; Han K
    Ann Clin Lab Sci; 2003; 33(1):32-8. PubMed ID: 12661896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC.
    Peng HX; Yang L; He BS; Pan YQ; Ying HQ; Sun HL; Lin K; Hu XX; Xu T; Wang SK
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27686880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
    Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
    Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
    Wang YR; Yan JX; Wang LN
    J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
    J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.